MaxCyte CFO resigns; appoints Ron Holtz as interim CFO; Q1 revenue at least $11M

MAXCYTE, INC.

Amanda Murphy resigns as CFO effective April 15, 2022; Ron Holtz (former CFO 2005-2020, CAO) named interim CFO.
Preliminary Q1 2022 revenue at least $11.0M, up 69% YoY from $6.5M.
Core business revenue at least $9.0M vs $6.5M; SPL program revenue $2.0M vs $0.0.
Sean Menarguez promoted to Director, Investor Relations.
Executive search firm Korn Ferry engaged to find a permanent CFO.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Ron Holtz

Interim Chief Financial Officer

MXCT · MAXCYTE, INC.

Effective: 2022-04-15
Filed: April 12, 2022, 7:59 PM ET

On April 8, 2022, the Board of Directors of the Company appointed Ron Holtz, currently the Company’s Senior Vice President and Chief Accounting Officer, as Interim Chief Financial Officer, effective upon Ms. Murphy’s departure.

Departed

Amanda L. Murphy

Chief Financial Officer

MXCT · MAXCYTE, INC.

Effective: 2022-04-15
Successor: Ron Holtz
Filed: April 12, 2022, 7:59 PM ET

On April 7, 2022, Amanda L. Murphy, Chief Financial Officer of the Company, resigned from that position, effective as of April 15, 2022, to pursue other interests.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ron Holtz was appointed as Interim Chief Financial Officer at MAXCYTE, INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On April 8, 2022, the Board of Directors of the Company appointed Ron Holtz, currently the Company’s Senior Vice President and Chief Accounting Officer, as Interim Chief Financial Officer, effective upon Ms. Murphy’s departure.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Amanda L. Murphy resigned as Chief Financial Officer at MAXCYTE, INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On April 7, 2022, Amanda L. Murphy, Chief Financial Officer of the Company, resigned from that position, effective as of April 15, 2022, to pursue other interests.

View on SEC.gov

MAXCYTE, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-045082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.